Tom Schimanski | Medicine and Dentistry | Best Researcher Award

Mr. Tom Schimanski | Medicine and Dentistry | Best Researcher Award  

Student at Universität Regensburg | Germany

Mr. Tom Schimanski is an emerging researcher at Universität Regensburg whose work bridges the intersection of medicine, surgery and biomedical innovation. His academic background reflects an early commitment to scientific rigor and medical advancement, culminating in advanced studies and a doctoral research focus within the Department of Plastic, Hand, and Reconstructive Surgery. Building upon a foundation of clinical training, he has developed extensive expertise in translational medicine, integrating laboratory research with real-world surgical applications. His scholarly engagement is marked by active participation in experimental studies addressing tissue regeneration, cellular responses, and cryopreservation methodologies for adipose and connective tissues. Mr. Tom Schimanski’s contributions to the scientific community are evident through his publications in internationally indexed journals such as Cells, where his research explores mechanisms of ferroptosis, biocompatibility of anesthetics, exosome mediated cellular communication, and innovative imaging approaches like multispectral optoacoustic tomography. With 3 published documents, 1 citation, and an h-index of 1, he exemplifies the diligence and precision of a young scientist dedicated to building a lasting impact in medical science. His ongoing collaborations with institutions such as Helmholtz Zentrum München further strengthen his multidisciplinary approach, combining cellular biology, materials science, and reconstructive medicine. Mr. Tom Schimanski’s research interests encompass tissue engineering, regenerative medicine, biomaterials development, and translational surgery, focusing on developing clinically viable strategies to enhance wound healing and graft preservation. His work also reflects a broader vision for integrating biotechnological innovations into surgical practice, fostering advancements that align patient safety with scientific discovery. Through his deep engagement in both experimental and clinical contexts, he continues to advance methodologies that could redefine regenerative outcomes and improve the sustainability of reconstructive procedures. With a growing research record and a strong foundation in evidence-based medicine, Mr. Tom Schimanski represents a new generation of clinician-scientists whose contributions are shaping the evolving landscape of biomedical research and surgical innovation. His pursuit of excellence underscores a commitment to translating science into tangible medical progress, marking him as a promising and impactful figure in contemporary medical research.

Profile: Scopus | Orcid

Featured Publications:

Schimanski, T., Loucas, R., Loucas, M., Brébant, V., Anker, A., Klein, S., Diesch, S. T., Pagani, A., & Prantl, L. (2025). Histological and immunohistochemical characteristics of mechanically processed adipose tissue A systematic review and meta-analysis. Cells, 14(21), 1664.

Schimanski, T., Prantl, L., Eigenberger, A., Felthaus, O., Loucas, R., Utpatel, K., & Steer, K. (2025). CELTPLUS fat increases the metabolic activity as well as the SVF-yield significantly when compared to CELT fat, even after cryopreservation with DMSO. Cells, 14(16), 1270.

Schimanski, T., Loucas, R., Loucas, M., Felthaus, O., Brébant, V., Klein, S., Anker, A., Frank, K., Siegmund, A., Pagani, A., & Prantl, L. (2025). Histology and immunohistochemistry of adipose tissue: A scoping review on staining methods and their informative value. Cells, 14(12), 898.

Eigenberger, A., Felthaus, O., Bartsch, A., Schimanski, T., Utpatel, K., & Prantl, L. (2025). The influence of sedimentation on the composition of the lipoaspirate and the effects on further mechanical processing. Cells, 14(8), 601.

Luca Roncati | Medicine and Dentistry | Best Researcher Award

Prof. Luca Roncati | Medicine and Dentistry | Best Researcher Award  

Professor at Link Campus University | Italy

Prof. Luca Roncati is an accomplished Italian physician-scientist, pathologist, and academic who has made outstanding contributions to medicine and dentistry through his pioneering research, teaching, and clinical leadership. He earned his Ph.D. in Pathology, building a solid academic foundation that has enabled him to excel in translational research across multiple domains including senology, gynecologic oncology, gynecopathology, and hematopathology. Currently, he serves as a Full Professor of Pathology at Link Campus University in Rome and as Head of the Women’s Health Department at the European Institute of Dermatology in Milan, where he integrates patient care with innovative research. His professional experience also extends to forensic pathology and editorial responsibilities, highlighting his multidisciplinary expertise and leadership in the scientific community. Prof. Luca Roncati’s research interests span cancer biology, nanopathology, women’s health, and infectious diseases, with significant contributions to the understanding of COVID-19 pathology, exemplified by several highly cited publications. His skills include advanced diagnostic pathology, molecular biology, nanotechnology applications in medicine, and academic mentorship, as well as the ability to translate complex findings into practical healthcare solutions. With over 227 publications, 1,726 citations by 1,064 documents, and an h-index of 23, his academic output reflects sustained global impact and recognition. His innovative work includes the description of the Roncati-Manenti triad and T rex lymphoma, and his authorship of more than 280 peer-reviewed publications in high-impact journals has positioned him as a global thought leader. Prof. Luca Roncati has received numerous honors as an award-winning author and inventor of anti-cancer patents, underscoring his capacity to merge science with innovation. In conclusion, Prof. Luca Roncati’s distinguished academic record, clinical leadership, and groundbreaking contributions to oncology, nanopathology, and women’s health make him a leading figure in medicine whose continued work promises to advance medical research, patient care, and global health standards.

Profile: Scopus

Featured Publications:

  1. Roncati, L. (2020). The COVID-19 syndrome: a clinical perspective. Clinical Immunology, 215, 108487.

  2. Roncati, L. (2020). Endothelial–platelet interactions in COVID-19. Annals of Hematology, 99(9), 1955–1956.

  3. Roncati, L. (2020). T rex lymphoma: a novel hematologic entity. Current Medical Research and Opinion, 36(3), 511–514.

  4. Roncati, L. (2017). Nanopathology: the health impact of nanoparticles. Nanotoxicology, 11(7), 884–888.

  5. Roncati, L. (2016). The Roncati–Manenti triad in gynecologic oncology. International Journal of Gynecological Cancer, 26(8), 1584–1585.

  6. Roncati, L. (2019). The forensic challenges in the study of nanoparticle exposure. Forensic Science International, 301, 309–315.

  7. Roncati, L. (2018). Molecular pathology insights into breast cancer. Pathology Research and Practice, 214(12), 2000–2005.